Novavax files emergency use listing with WHO for Covid-19 vaccine

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO

Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics

The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies

Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021

Solve.Care and AliveCor partner to connect KardiaMobile users with physicians

The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings

Transforming Healthcare Through AI

PLI scheme has the potential to make India a pharma hub: Dr Mandaviya

FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year

Novavax files for approval of its Covid-19 vaccine in the UK

Filing marks first protein-based vaccine submitted to MHRA for authorization

Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity

Support from DFC will help produce one billion vaccine doses by the end of 2022

10x Genomics opens Singapore manufacturing hub

Strengthens supply chain continuity with first manufacturing facility outside of the U.S.

We are marketing all our products globally: Samit Jain, MD, PLUSS

Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business